EMA Mulls Dropping Comparative Efficacy Trials For Biosimilars
European Agency Kicks Off Consultation On Whether Such Studies Are Always Necessary
• By David Wallace
Are comparative efficacy studies necessary for all biosimilars? • Source: Shutterstock 
